Prostaglandin periorbitopathy is a group of periocular changes caused by topical prostaglandin analogs used for glaucoma.

The drops lower intraocular pressure well and need only one dose a day. However, they act on tissues around the eye as well as on the ciliary body, and many patients notice the cosmetic changes long before their doctor does.


What Is Prostaglandin Periorbitopathy?

The term covers several signs that often appear together. These include a deepened upper lid sulcus, loss of lower lid fullness, lash growth and darker lid skin, and some authors also include a tight orbit, mild ptosis and inferior scleral show.

Which Drops Cause It

All prostaglandin analogs can produce these changes, however published series report them most often with bimatoprost. Travoprost appears intermediate, while latanoprost seems to cause them least often.

Test your knowledge 10 questions from this article
Choroida · Slit-lamp imaging

All-fit Slit-Lamp Adapter

Record and share exactly what you see at the slit lamp. One adapter fits any slit lamp or surgical microscope — and any smartphone.

From Choroida — the team behind this site

Deepened Sulcus in Prostaglandin Periorbitopathy

Deepening of the upper eyelid sulcus is the hallmark sign. The upper lid looks hollow, and the lid crease may rise. Patients often describe it as looking tired or older, and because the change is gradual, family members may notice it first.

Orbital Fat Atrophy and Enophthalmos

Laboratory work suggests that FP receptor stimulation inhibits adipocyte differentiation, and as a result, orbital fat volume decreases over time. The globe can then sit slightly deeper in the orbit, and mild enophthalmos is best judged against the fellow eye.

Lower Lid Changes and Lid Tightness

Lower lid fat pads may flatten, and baggy lids can appear smoother. In addition, the lids often feel firm and less elastic, and this tightness can make lid eversion and examination harder.

Eyelash Growth and Trichomegaly

Lashes grow longer, thicker and darker during treatment. Then, with unilateral therapy, the asymmetry becomes obvious to the patient, and vellus hairs on the lid skin may also darken.

Periocular Skin Pigmentation

Prostaglandins increase melanin production in lid skin, and therefore the lids may develop a brown or gray tint. Blotting excess fluid after instillation is a simple preventive habit.

Iris Color Change

Iris darkening is generally considered permanent, and it occurs most often in mixed-color irides, such as green-brown or hazel eyes. Warn patients before starting therapy, especially with one-eyed treatment.

Grading Prostaglandin Periorbitopathy

Simple grading systems combine cosmetic signs with how easily the examiner can perform tonometry. For example, one Japanese system grades eyes from none to severe, and a standardized photograph at baseline helps document later change.

Prostaglandin Periorbitopathy (Sunken Eyes): Drop Effect

Asymmetry as a Diagnostic Clue

Unilateral or asymmetric treatment produces asymmetric findings, so ask which eye receives drops and for how long. A hollow sulcus only on the treated side strongly suggests a drug effect.

Differential Diagnosis of Prostaglandin Periorbitopathy

  • Involutional fat loss with aging
  • Silent sinus syndrome with enophthalmos
  • Orbital floor fracture
  • Weight loss or lipodystrophy
  • Aponeurotic ptosis with a high lid crease

Is Prostaglandin Periorbitopathy Reversible?

Sulcus deepening often improves after stopping the drug or switching agents. For example, one study showed recovery after switching from bimatoprost to latanoprost. However, recovery is often partial and may take months, while skin pigment and lash changes usually regress and iris color does not.

IOP Measurement in Prostaglandin Periorbitopathy

Tight lids make Goldmann applanation technically difficult, and pressure on the globe while holding the lids can falsely raise readings. Therefore, avoid pressing on the globe when you hold the lids open (see IOP measurement pitfalls).

Surgical Impact of Prostaglandin Periorbitopathy

A deep-set globe and tight lids reduce surgical exposure. As a result, trabeculectomy, tube surgery and cataract surgery can be harder to perform, so plan exposure carefully and consider a traction suture.

Switching Therapy

Switching to latanoprost may reduce progression in a susceptible patient. Alternatively, consider a beta blocker, a carbonic anhydrase inhibitor or a rho kinase inhibitor, and review all classes with the patient (see glaucoma eye drops).

Counseling Patients About Prostaglandin Periorbitopathy

First, explain the possible changes before the first prescription. Next, reassure patients that most changes improve after stopping the drug, but they should never stop drops without a pressure plan. Finally, cosmetic concerns can reduce adherence, so address them openly.

Pitfalls to Avoid

  • Do not label a hollow sulcus as aging without a drug history
  • Never stop prostaglandins without arranging alternative pressure control
  • Do not squeeze tight lids during applanation
  • Avoid promising full reversal of iris color

All-fit smartphone adapter on a slit lampFundus Explorer Pro smartphone fundus camera
Choroida · Clinical imaging

Document what you see

Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.

From Choroida — the team behind this site

References

  1. Kucukevcilioglu M, Bayer A, Uysal Y, Altinsoy HI. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost. Clin Exp Ophthalmol. 2014;42:126-131.
  2. Inoue K, Shiokawa M, Wakakura M, Tomita G. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs. J Glaucoma. 2013;22:626-631.
  3. Sakata R, Shirato S, Miyata K, Aihara M. Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost. Jpn J Ophthalmol. 2013;57:179-184.
  4. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol. 1997;124:544-547.
  5. Tanito M, Ishida A, Ichioka S, et al. Proposal of a simple grading system integrating cosmetic and tonometric aspects of prostaglandin-associated periorbitopathy. Medicine (Baltimore). 2021;100:e26874.

Test yourself

A few questions straight from this article.

1 / 10 0 correct
  1. What is the hallmark sign of prostaglandin periorbitopathy?

Ahmed Ophthalmologist

Writes and reviews the clinical articles on Educate. Every post is checked against peer-reviewed sources before it goes live.